Epithelial borderline ovarian tumors: clinicopathological characteristics, management options, and diagnostic role of intraoperative consultation

Aim: The objective of the present study was to evaluate clinicopathological and surgical features, accuracy of frozen section in patients with serous and mucinous borderline ovarian tumors (BOTs) treated in this clinic. Materials and Methods: A retrospective analysis of all patients treated for BOTs at Ankara Oncology Education and Research Hospital between 2008 and 2015 was performed. Data were obtained from hospital records and from the patients by phone. Fifteen patients were identified. Results: The mean age at diagnosis was 38.20 ± 7.37 (27-50) years. Sixty percent of the patients in this study were under 40 years of age. At the time of diagnosis, 93.4% of the patients had Stage I disease and 6,6% of the patients had advanced-stage disease. All patients underwent surgery. Serous histology was found in 73.3% of the patients. Forty-six percent of patients underwent fertility-sparing surgery (FSS) and 53.3% radical surgery. Conclusion: BOTs have perfect prognosis, and FSS may be applied to patients at reproductive ages desiring to protect their fertility.

Borderline ovarian tumors; Fertility-sparing surgery; Frozen section.

[1] Trillsch F., Mahner S., Vettorazzi E., Woelber L., Reuss A., Baumann K.: “Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study”. Br J Cancer, 2015, 112, 660.

[2] Seong S.J., Kim da H., Kim M.K., Song T.: “Controversies in borderline ovarian tumors”. J. Gynecol. Oncol., 2015, 26, 343.

[3] Vasconcelos I., de Sousa Mendes M.: “Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk”. Eur. J. Cancer, 2015, 51, 620.

[4] Morice P.: “Borderline tumors of the ovary and fertility”. Eur. J. Cancer, 2006, 42, 149.

[5] Massad L.S. Jr., Hunter V.J., Szpak C.A., Clarke-Pearson D.L., Creasman W.T.: “Epithelial ovarian cancers of low malignant potential”. Obstet. Gynecol., 1991, 78, 1027.

[6] Gungor T., Cetinkaya N., Yalcin H., Ozdal B., Ozgu E., Baser E.: “Retrospective evaluation f borderline ovarian tumors: single center experience of 183 cases”. Arch. Gynecol. Obstet., 2015, 291, 123.

[7] Loizzi V., Selvaggi L., Leone L., Latorre D., Scardigno D., Magazzino F , Cormio G.: “Borderline epithelial tumors of the ovary: Experience of 55 patients”. Oncol. Lett., 2015, 9, 912.

[8] McCluggage W.G.: “The pathology and controversial aspects of ovarian borderline tumors”. Curr. Opin. Oncol., 2010, 22, 462.

[9] Basaran D., Salman M.C., Calis P., Ozek A., Ozgul N., Usubutun A., Yuce K.: “Diagnostic accuracy of intraoperative consultation (frozen section) in borderline ovarian tumours and factors associated with misdiagnosis”. J. Obstet. Gynecol., 2014, 34, 429.

[10] Ilvan S., Ramazanoğlu R., Ulker –Akyıldız E., Calay Z., Beşe T., Oruc N.: “The accuracy of frozen section(intraoperative consultation) in the diagnosis of ovarian masses”. Gynecol. Oncol., 2005, 97, 395.

[11] Kayıkcıoglu F., Pata O., Cengiz S., Tulunay G., Boran N., Yalvac S., Kose F.: “Accuracy of frozen section diagnosis in borderline ovarian malignancy”. Gynecol. Obstet. Invest., 2000, 49, 187.

[12] Mederios L.R., Rosa D.D., Edelweiss M.I., Stein A.T., Bozzetti M.C., Zelmanowicz A., et al.: “Accuracy of frozen-section analysis in the diognosis of ovarian tumors: a systematic quantitative review”. Int. J. Gynecol. Oncol., 2005, 15, 192.

[13] Kim J.H., Kim T.J., Park Y.G., Lee S.H., Lee C.W., Song M.J., et al.: “Clinical analysis of intra-operative frozen-section proven borderline tumors of the ovary”. J. Gynecol. Oncol., 2009, 20, 176.

[14] Tinelli R., Tinelli A., Tinelli F.G., Cicinelli E., Malvasi A.: “Conservative surgery for borderline ovarian tumors. A review”. Gynecol. Oncol., 2006, 100, 185.

[15] Boran N., Cil A.P., Tulunay G., Ozturkoglu E., Koc S., Bulbul D., Kose M.F.: “Fertility and recurrence results of conservative surgery for borderline ovarian tumors”. Gynecol. Oncol., 2005, 97, 845.

[16] Kristensen G.S., Schledermann D., Mogensen O., Jockhumsen K.M.: “The value of random biopsies, omentectomy, and hysterectomy in operations for borderline ovarian tumors”. Int. J. Gynecol. Cancer, 2014, 24, 874.

[17] Harter P., Gerhenson D., Lhomme C., Lecuru F., Ledermann J., Provencher D.M., et al.: “Gynecologic Cancer Intergroup(GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors)”. Int. J. Gynecol. Oncol. Cancer, 2014, 24, 5.

[18] Kleppe M., Bruls J., Van Gorp T., Massuger L., Slangen B.F., Van de Vijver K.K., et al.: “Mucinous borderline tumours of the ovary and the appendix: a retrospective study and overview of the literature”. Gynecol. Oncol., 2014, 133, 155.

[19] Romagnolo C., Gadduci A., Sartori E., Zola P., Maggino T.: “Management of borderline ovarian tumors: Results of an Italian multicenter study”. Gynecol. Oncol., 2006, 101, 255.

[20] Hannibal C.G., Vang R., Junge J., Frederiksen K., Kjaerbye-Thygesen A., Andersen K.K., et al.: “A nationwide study of serous “borderline” ovarian tumors in Denmark 1978-2002: centralized pathology review and overall survival compared with the general population”. Gynecol. Oncol., 2014, 134, 267.

[21] Ziari K., Soleymani E., Alizadeh K.: “Survival analysis and prognosis for patients with serous and mucinous borderline ovarian tumors: 14-year experience from a tertiary center in Iran”. Acta Med. Iran, 2015, 53, 199.

[22] Kane A., Uzan C., Rey A., Gouy S., Camatte S., Pautier P., et al.: “Prognostic factors in patients with ovarian serous low malignant potential (borderline)tumors with peritoneal implants”. Oncologist, 2009, 14, 591.

[23] Seidman J.D., Kurman R.J.: “Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators”. Hum. Pathol., 2000, 31, 539.

[24] Gershenson D.M., Silva E.G., Levy L., Burke T.W., Wolf J.K., Tornos C.: “Ovarian serous borderline tumors with invasive peritoneal implants”. Cancer, 1998, 82, 1096.

[25] Silva E.G., Gershenson D.M., Malpica A., Deavers M.: “The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants in time dependent”. Am. J. Surg. Pathol., 2006, 11, 1367.

[26] Guvenal T., Dursun P., Hasdemir P.S., Hanhan M., Guven S., Yetimalar H., et al.: “Effect of surgical staging on 539 patients with borderline ovarian tumors: a Turkish Gynecologic Oncology Group study”. Gynecol. Oncol., 2013, 131, 546.